Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trial
一项开放标签、非随机 I/II 期试验的结果表明,动员急性卒中患者的造血 CD34+ 前体细胞是安全的。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0023099
Boy, Sandra; Sauerbruch, Sophie; Kraemer, Mathias; Schormann, Thorsten; Schlachetzki, Felix; Schuierer, Gerhard; Luerding, Ralph; Hennemann, Burkhard; Orso, Evelyn; Dabringhaus, Andreas; Winkler, Jürgen; Bogdahn, Ulrich